Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For August 2020

OHIO:  The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for August 2020. These numbers include:

  • 168,678 Recommendations
  • 131,654 Registered patients
    • 9,267 Patients with Veteran Status
    • 9,694 Patients with Indigent Status
    • 724 Patients with a Terminal Diagnosis
  • 103,642 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 14,775 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

OLCC Compliance Education Bulletin: Medical Sales To A Designated Caregiver

OREGON: The OLCC has added a “Bulletins” section to its Recreational Marijuana Program website with important information for licensees and marijuana worker permit holders.

The Oregon Liquor Control Commission is providing the following information to: recreational marijuana licensees.

The bulletin is part of OLCC’s compliance education. It is important that you read it, and understand it.If you don’t understand it please contact the OLCC for help.

Failure to understand and follow the information contained in this bulletin could result in an OLCC rules compliance violation affecting your ability to work or operate your business.

A bulletin previously issued by Metrc inadvertently provided the incorrect date for when the CTS functionality change takes place.  The change in Metrc is effective starting September 14, 2020.

Bulletin CE2020-04 covers the following issues:

  • Medical Sales to a Caregiver
  • Sales Limits to Caregivers and Patients
  • New Metrc Functionality – Designating Caregiver Sales

Compliance Education Bulletin CE2020-04 provides updated guidance on medical sales to a Designated Caregiver, sales limits caregivers and patients, and changes in Metrc functionality for caregiver sales.

Medical Sales to a Designated Caregiver

The Oregon Medical Marijuana Program (OMMP) provides for patients to designate a caregiver who can purchase and possess marijuana items for the patient. The caregiver’s card references both the caregiver’s and patient’s registration number.

Effective September 14, 2020 new functionality in the Cannabis Tracking System (CTS), Metrc, now allows retailers to designate sales as “caregiver” sales, in addition to consumer and patient. When a caregiver sales is recorded, either manually in Metrc or through API or CSV upload, the retailer must input both the patient and caregiver numbers.

Rules allow for a patient and their caregiver to jointly possess up to 24 ounces of usable marijuana. This is to say, a retailer may sell up to the daily limit under both the patient’s and caregiver’s cards under the caregiver sales. This will go into effect when the daily sales limit returns to 8 ounces on September 18, 2020.

The bulletin describes the new functionality in Metrc and provides a step by step guide to entering a caregiver sales manually in the system. Metrc has previously provided API partners with details on this addition, so they should be ready to use this functionality in their systems.

Questions regarding the contents of this bulletin may be sent to marijuana.cts@oregon.gov.

Curaleaf’s Select Elite Live Cartridges Reach $1M Sales In Florida Within 30 Days

MASSACHUSETTS  Curaleaf Holdings, a leading vertically integrated cannabis operator in the United States, today announced that its line of Select Elite Live cartridges has reached $1 million in sales since launching in the Florida medical market on August 6.Select Elite Live features high quality, high potency oil with a wide variety of strain-specific flavor and effects. Curaleaf will unveil additional Select product offerings to Florida’s medical patients later this year, including the best-selling high potency broad spectrum Select Elite cartridges. As a recognized industry leader, Select is committed to maintaining the highest quality control standards and testing transparency and delivering the best experience possible.

“We are thrilled to have received such a positive response to Elite Live from our Florida patients, and look forward to continuing to provide innovative new products for their cannabis needs,” said Joe Bayern, President of Curaleaf. “The immediate success of Elite Live in Florida speaks to the power of the Select brand, and we are confident about our continued growth in the state.”

Select, known as America’s #1 Cannabis Oil Brand, has been on a path of rapid expansion since it was acquired by Curaleaf in February 2020. Select products are now available in over 950 independent dispensaries across 12 states, including ArizonaCaliforniaColoradoConnecticutFloridaMarylandMichiganNevadaOklahomaOregonMassachusetts and Maine. The Select brand will continue to expand across the U.S. with its launch into Ohio’s medical market later this month.

Curaleaf has continued its retail expansion in Florida, recently announcing the opening of its Clearwater and South Tampa locations and plans to open a new Brandon area dispensary later this month.

Curaleaf Opens New Cannabis Dispensary In Clearwater, Florida

New Location Marks Curaleaf’s 29th Storefront in Florida and 89th Nationwide

FLORIDA: Curaleaf Holdings, a leading vertically integrated cannabis operator in the United States and one of the largest cannabis operators in Florida, announced today that it has opened a new dispensary in Clearwater, Florida, marking its 29th retail location in the state.Curaleaf Clearwater, located at 2082 Gulf to Bay Boulevard, will carry a wide range of Curaleaf and Select brand products. Select, known as America’s #1 cannabis oil brand now available in 12 states, launched earlier this month in Florida with Select Elite Live, the brand’s new enhanced live resin product, which combines high-quality THC oil and live resin high-terpene extract. The company also recently launched the first-to-market Curaleaf sublingual tablets. The Clearwater location is the first of three new medical dispensaries the company plans to open in the market this quarter.

“Curaleaf remains committed to the Florida market and its patients by providing high-quality medical cannabis products and new consumption formats that make cannabis accessible for all,” said Joe Bayern, President at Curaleaf. “We are thrilled to open Clearwater and support the health and wellness needs of more Floridians.”

Florida’s continued growth in patient registration makes it one of the nation’s fastest-growing medical cannabis markets in the country. Currently, there are over 394,000 medical patients enrolled in the Florida program – about 1.8% of the state’s population – with approximately 5,000 new patients joining each week.

In response to COVID-19, Curaleaf continues to implement new policies and procedures, including curbside services and contactless and cashless payment through approved credit and debit card services, to keep patients, customers and employees safe during this time. To see Curaleaf’s dispensary locations in Florida, please visit www.curaleaf.com/locations/#florida.

Oklahoma Medical Marijuana Authority Names New Director

OKLAHOMA:  The deputy director of the Oklahoma Medical Marijuana Authority will serve as interim director of the authority, officials announced Friday.

Kelly Williams replaces Travis Kirkpatrick, who was recently named deputy commissioner of prevention and preparedness at the Oklahoma State Department of Health.

Kirkpatrick, who will oversee the OMMA from his new position, chose Williams for the interim post. Kirkpatrick had been named director of the authority in January after serving as interim director for about three months.

“This is a young agency and we have seen massive growth over the past two years,” Williams said in a statement. “I look forward to the challenges and the rewards of growing the Oklahoma Medical Marijuana Authority into an agency that will make Oklahomans proud.”

NJ Department Of Health Issues Permit To Grow Medical Marijuana

NEW JERSEY: The New Jersey Department of Health issued last month a permit to Justice Grown in Ewing to begin growing medical marijuana. The permit was issued after a comprehensive review including several site inspections, background checks of its corporate officers and a review of its security operations and cultivation facility.

“As our program continues to grow, the Department wants to ensure that we also continue to increase access for all patients,” Health Commissioner Judith Persichilli said. “This new permit brings the total number of operational medical marijuana cultivation sites in the state to 12.”

Justice Grown is the last Alternative Treatment Center (ATC) to receive a cultivation permit among the awards made by the Division of Medicinal Marijuana in December 2018. Earlier this year, the Division issued cultivation permits to Verano in Readington, MPX NJ in Pleasantville, TerrAscend in Boonton Township, and Columbia Care NJ in Vineland.

Once Justice Grown receives its permit to dispense, the Division will notify the patients and caregivers by email of the opening date.  Justice Grown’s dispensary will also be located in Ewing.

There are nine ATCs currently dispensing medical marijuana: Greenleaf Compassion Center of Montclair, Compassionate Care Foundation of Egg Harbor, Garden State Dispensary of Woodbridge and Union Township, Breakwater Alternative Treatment Center of Cranbury, Curaleaf NJ, Inc. in Bellmawr, Harmony Dispensary in Secaucus and Rise in Paterson and Compassionate Care Foundation of Atlantic City.

Program participation continues to grow. There are now 75,468 patients, 2,949 caregivers and 1,149 physicians participating in the program.

Patients and caregivers can visit the Division’s website if they choose to change their preferred ATC. The change can also be made by calling the Customer Service Unit of the Division of Medicinal Marijuana at 844-419-9712 and does not require changing ID cards.

Patients can refer to the FAQ section of the Division of Medicinal Marijuana website for additional information. Active physicians enrolled in the program are listed by county and medical specialty.

New Jersey residents interested in registering for Medicinal Marijuana can click here.

Follow the New Jersey Department of Health on Twitter @njdeptofhealth, Facebook /njdeptofhealth, Instagram@njdeptofhealth and Snapchat @njdoh.

For more information, visit our homepage at nj.gov/health.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For April 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for April 2020. These numbers include:

CANADA: Cannalogue Introduces COVID-19 Compassionate Care Program For Medical Cannabis

Physician-led online marketplace offers discount of 20-50% on select products for frontline workers, seniors and financially strained

CANADA: In response to the closure of storefront retailers due to COVID-19, online marketplace Cannalogue announced today a new Compassionate Care Program that seeks to provide better access to medical cannabis for all Canadians. 

Qualified candidates including first responders, seniors, nurses, teachers, and those facing financial strain due to work shortage/layoffs can enroll in the program to receive selected products at a discount of 20-50%.  The doctor-recommended, Health Canada approved products include oils, capsules, and dried flowers from as low as $3.50/gram.  As the most inclusive program in Canada, Cannalogue’s Compassionate Care Program is also available to veterans, individuals currently enrolled in a disability, federal or provincial assistance program and Indigenous peoples.

“COVID-19 has had a devastating effect on all Canadians” says President and CEO, Dr. Mohan Cooray. “As a result, we’ve seen an upsurge in cannabis use among patients managing symptoms such as pain, anxiety, difficulty sleeping, and stress – especially from symptoms related to COVID-19 isolation.  Cannabis is a natural plant medicine that can be used safely to manage mental health issues without the dependency effects we see from alcohol, opioids or narcotics.  During this unprecedented time and without access to storefront retailers, we want to help Canadians receive the products they need,” he says.

Additionally, with limited access to doctors or pharmacists during self-isolation, Cannalogue’s medical staff can assess and provide dosage recommendations over the phone.  “Cannalogue is an essential national medical service that Health Canada has confirmed will be fully available to patients during the pandemic. No matter how long we face the challenges of COVID-19, Cannalogue will be here to help,” says Dr. Cooray.

Ohio Medical Marijuana Control Program Mandatory Product Recall – 3/13/2020

OHIO: The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on plant material cultivated by Pure Ohio Wellness. This recall is being initiated by the MMCP because product that did not receive the full battery of required testing was sold at dispensaries. The product was not tested for heavy metals, water activity, microbials, mycotoxins, or foreign matter. The MMCP has initiated an investigation into the noncompliance and identified product samples to be tested. These results will be communicated publicly.

AFFECTED PRODUCT:

Product Name: Papaya Punch, Hiker’s Blend, and Tahoe Jack

Purchase Dates: May 10, 2019 – Present

Cultivator Name: Pure Ohio Wellness

Product ID:
• M00000022503: Tier 1 Vap-Hybrid-16.4-.04-Papaya Punch
• M00000022504: Tier 1 Vap-Hybrid-16.9-.07-Hikers Blend
• M00000022506: Tier 1 Vap-Hybrid-18.6-.03-Tahoe Jack
• M00000028027: Tier 1 Vap-Hybrid-14.21-0.05
• M00000032648: Tier 1 Vap-Hybrid-14.48-0.03
• M00000036302: Tier 1 Vap-Sativa-15.50-0
• M00000036303: Tier 1 Vap-Sativa-18.50-0
• M00000036307: Tier 1 Vap-Sativa-14.75-0
• M00000039234: Tier 1 Vap-Sativa-18.50-0 (103) 28.3g
• M00000039235: Tier 1 Vap-Sativa-14.75-0 (104) 8.49g
• M00000039236: Tier 1 Vap-Sativa-14.75-0 (104) 28.3g
• M00000039239: Tier 1 Vap-Sativa-14.75-0 (107) 8.49g
• M00000039240: Tier 1 Vap-Sativa-14.75-0 (107) 28.3g
• M00000039241: Tier 1 Vap-Sativa-15.50-0 (108) 8.49g
• M00000039242: Tier 1 Vap-Sativa-15.50-0 (108) 28.3g

No reports of adverse reactions for this product have been reported to the MMCP at this time.

Patients who have purchased the recalled product should stop using it. All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 90-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.

Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

Acreage Announces Opening Of The Botanist Dispensary in Florida

NEW YORK: Acreage Holdings, one of the largest vertically integrated, multi-state operators of cannabis licenses and assets in the U.S., today announced the opening of The Botanist in Spring Hill, Florida, a suburb of Tampa.  The medical cannabis dispensary is Acreage’s first retail location in the state.

With the opening of the dispensary, located at 10520 Spring Hill Road, Acreage now owns or has management services, consulting or other agreements (including pending acquisitions) for 32 operational dispensaries in 13 states, including 14 The Botanist branded dispensaries.

Developed by Acreage, The Botanist is both a retail and product brand, deeply rooted in health and wellness, and focused on the holistic power of cannabis to help individuals live balanced lifestyles. The Botanist offers a wide selection of cannabis-derived products and features a “science meets nature” retail design reminiscent of a 19th century botanist laboratory. Offering a warm and inviting environment in which to learn about the healing properties of the cannabis plant from trained patient care specialists, the Spring Hill Botanist dispensary includes a private consultation room, The Botanist’s signature “green foliage wall,” and much more.